Industry Insights

  1. Merck, Walmart, IBM, & KPMG's FDA Blockchain Pilot: What We Learned 6/17/2020

    IBM, KPMG, Merck & Co., and Walmart successfully completed an FDA pilot program that demonstrated how blockchain technology can be used to help meet the Drug Supply Chain Security Act (DSCSA) requirements to verify, track, and trace prescription medicines and vaccines distributed within the U.S. 

  2. Reflecting On 2025: Innovation & Investment 12/29/2025

    As capacity expands and capabilities mature, CDMOs with global scale and advanced injectable expertise are becoming critical partners for bringing complex sterile drug products to market.

  3. How To Solve Difficult Challenges Of Cell&Gene Therapy Manufacturing 2/17/2023

    Explore how paper batch records hold back cell and gene therapy manufacturing and the digital solutions that could help improve efficiency.

  4. Key Considerations For An Effective Commercial Strategy 5/11/2022

    Find out the questions sponsors can ask to ensure they have the best chance to develop an asset with commercial potential.

  5. Targeting Solid Tumors with Cell Therapies 3/29/2022

    Despite the remarkable responses in autologous CAR-T for hematological indications, success has not yet translated into solid tumor indications, which represent a much larger opportunity in oncology. The question is “Why and how do we get there?”

  6. Rethinking Manufacturing Processes To Identify Green Opportunities

    Reducing the carbon footprint of your pharmaceutical fine chemicals manufacturing process requires a shift from the traditional process development approach. Sustainability requires revolutionary changes.

  7. The Small Biotech's Checklist For FIH Trials 8/27/2024

    Getting medicine to its first patients is enormously complex with many players and moving parts. These are the critical steps.

  8. Best Practices For Chromatography Column Packing 12/6/2024

    Proper packing for resin is crucial to prevent issues like cracking or channeling which can lead to process disruptions and product loss.

  9. Is It Time To Leave The Biotech Incubator? 6/8/2020

    Kavitha Iyer Rodrigues, founder of Zumutor Biologics, Inc. offers experience-based insight into maximizing the value of incubation time, and knowing when it’s time to spread your wings and step out of the nest.

  10. The Ins & Outs Of Technology Transfers In Pharma Manufacturing 6/6/2016

    Technology transfer — the handover of knowledge between organizations — is the seminal event in all outsourcing arrangements, particularly for pharmaceutical manufacturing. Tech transfers may occur internally, within a company, externally, involving two or more corporate entities, or involve successive lifecycle stages, such as development and scale-up. External tech transfers prompt the most discussion, and contractors and sponsors have each developed their own unique tech transfer subcultures